Elevai Labs Inc. has entered into an Asset Purchase Agreement to sell most of its assets related to Elevai Skincare to Cutis Cura Corporation for shares valued at approximately $1,075,463 and additional cash payments based on future sales. The deal includes a cash payment of $56,525 and potential earnout payments based on sales performance over the next five years.